Gender-independent efficacy of mesenchymal stem cell therapy in sex hormone-deficient bone loss via immunosuppression and resident stem cell recovery

Osteoporosis develops with high prevalence in both postmenopausal women and hypogonadal men. Osteoporosis results in significant morbidity, but no cure has been established. Mesenchymal stem cells (MSCs) critically contribute to bone homeostasis and possess potent immunomodulatory/anti-inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Sui, Bing-Dong, Chen, Ji, Zhang, Xin-Yi, He, Tao, Zhao, Pan, Zheng, Chen-Xi, Li, Meng, Hu, Cheng-Hu, Jin, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297134/
https://www.ncbi.nlm.nih.gov/pubmed/30559383
http://dx.doi.org/10.1038/s12276-018-0192-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297134/
https://www.ncbi.nlm.nih.gov/pubmed/30559383
http://dx.doi.org/10.1038/s12276-018-0192-0

Ejemplares similares